Business Context and Reporting Period
This Form 6-K filing by CollPlant Holdings Ltd. (also referred to as Collplant Biotechnologies Ltd) covers the period ending February 6, 2018. The report discloses changes in insider holdings as required by the Israel Securities Authority and the Tel Aviv Stock Exchange.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a disclosure of equity transactions rather than a financial performance report.
Material Changes
- Insider Acquisition: On February 5, 2018, Ami Sagi purchased 610,499 ordinary shares on the Tel Aviv Stock Exchange.
- Updated Ownership: Following the purchase, Mr. Sagi holds 19,304,045 ordinary shares, representing approximately 11.3% of the company's outstanding ordinary shares.
- Exclusions: The ownership percentage excludes 253,181 warrants held by Mr. Sagi to purchase 84,394 ordinary shares, as well as a warrant issuable under a Securities Purchase Agreement dated November 9, 2017.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is limited to the reporting of the specific share transaction.
Investor Verification Checklist
- Verify the total number of outstanding ordinary shares to confirm the 11.3% ownership calculation.
- Review the terms of the Securities Purchase Agreement dated November 9, 2017, regarding the warrant issuable to Mr. Sagi.
- Confirm the current status and exercise price of the 253,181 warrants held by Mr. Sagi.